Pharmaceutical Executive March 6, 2024
Miranda Schmalfuhs

In this Pharmaceutical Executive interview, Daniel Ayala, Chief Security and Trust Officer, Dotmatics, dives into the greatest threats to the integrity of data in R&D and threats presented by hackers.

In a world rife with optimism about the good that AI can do, what threat is presented to pharma by bad actors, like hackers, but for their own nefarious purposes?

AI brings a lot of potential benefits, AI accelerates a lot of thinking, it can contemplate a lot of data, it can, it can help us, you know, filter out things. And I’m not going to go into the cautions of AI in the drug discovery process. But I’ll talk about the way AI. The way we use AI or...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Big Data, Biotechnology, Cybersecurity, Interview / Q&A, Pharma, Pharma / Biotech, Technology, Trends
Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says
Google DeepMind CEO: AI-Designed Drugs Coming to Clinical Trials in 2025
DOJ Accuses Walgreens of Filling Millions of Illegitimate Prescriptions
DOJ sues Walgreens for allegedly filling millions of illegal prescriptions, including opioids
Beyond the stethoscope: the AI-powered revolution and personalized medicine will shape the next era of U.S. health care

Share This Article